All Stories

  1. Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014–2015)

    Article • Journal of Chemotherapy, May 2019, Taylor & Francis

    Dr. Mariana Castanheira, Helio S Sader

  2. Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype

    Article • mSphere, September 2018, ASM Journals

    Dr. Mariana Castanheira

  3. Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

    Article • Infection and Drug Resistance, September 2018, Dove Medical Press

    Helio S Sader, David Greenberg, Dr. Mariana Castanheira

  4. Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010–2016): concomitant analysis of oritavancin in vitro activity

    Article • Journal of Chemotherapy, July 2018, Taylor & Francis

    Helio S Sader, Dr. Mariana Castanheira

  5. In VitroActivity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-ResistantEnterobacteriaceaeand Isolates Carrying Carbapenemase Genes

    Article • Antimicrobial Agents and Chemotherapy, June 2018, ASM Journals

    Dr. Mariana Castanheira

  6. Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations

    Article • Journal of Clinical Microbiology, February 2018, ASM Journals

    Dr. Mariana Castanheira

  7. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the...

    Article • Antimicrobial Agents and Chemotherapy, December 2017, ASM Journals

    Dr. Mariana Castanheira

  8. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans

    Article • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals

    Dr. Mariana Castanheira

  9. Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

    Article • Antimicrobial Agents and Chemotherapy, June 2017, ASM Journals

    Dr. Mariana Castanheira

  10. Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

    Article • Antimicrobial Agents and Chemotherapy, May 2017, ASM Journals

    Dr. Mariana Castanheira

  11. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

    Article • Antimicrobial Agents and Chemotherapy, January 2017, ASM Journals

    Dr. Mariana Castanheira

  12. Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying blaKPC Collected in U.S. Hospitals from 2012 to 2015

    Article • Antimicrobial Agents and Chemotherapy, December 2016, ASM Journals

    Dr. Mariana Castanheira

  13. Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancinin vitropotency

    Article • Journal of Antimicrobial Chemotherapy, September 2016, Oxford University Press (OUP)

    Dr. Mariana Castanheira

  14. Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012–2014

    Article • Surgical Infections, August 2016, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  15. Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011–2014)

    Article • International Journal of Antimicrobial Agents, August 2016, Elsevier

    Dr. Mariana Castanheira

  16. Detection ofmcr-1among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Dr. Mariana Castanheira

  17. Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Dr. Mariana Castanheira

  18. Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013)

    Article • Diagnostic Microbiology and Infectious Disease, July 2016, Elsevier

    Dr. Mariana Castanheira

  19. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center: Table 1.

    Article • Clinical Infectious Diseases, June 2016, Oxford University Press (OUP)

    Dr. Mariana Castanheira

  20. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, againstCandidaandAspergillusspp., including echinocandin- and azole-resistant isolates

    Article • Journal of Antimicrobial Chemotherapy, June 2016, Oxford University Press (OUP)

    Dr. Mariana Castanheira

  21. In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011–2013)

    Article • International Journal of Antimicrobial Agents, June 2016, Elsevier

    Dr. Mariana Castanheira

  22. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)

    Article • Diagnostic Microbiology and Infectious Disease, June 2016, Elsevier

    Dr. Mariana Castanheira

  23. Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence ofAcinetobacter baumanniiStrains Displaying Elevated Tigecycline MIC Values in Latin America

    Article • Microbial Drug Resistance, June 2016, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  24. Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates

    Article • Antimicrobial Agents and Chemotherapy, May 2016, ASM Journals

    Dr. Mariana Castanheira

  25. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014

    Article • Antimicrobial Agents and Chemotherapy, April 2016, ASM Journals

    Helio S Sader, Dr. Mariana Castanheira

  26. Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata

    Article • International Journal of Antimicrobial Agents, April 2016, Elsevier

    Dr. Mariana Castanheira

  27. Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Dr. Mariana Castanheira

  28. Ceftaroline activity tested against viridans group streptococci from US hospitals

    Article • Diagnostic Microbiology and Infectious Disease, March 2016, Elsevier

    Dr. Mariana Castanheira

  29. In VitroActivity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014

    Article • Antimicrobial Agents and Chemotherapy, January 2016, ASM Journals

    Dr. Mariana Castanheira

  30. Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in anIn VitroInfection Model

    Article • Antimicrobial Agents and Chemotherapy, January 2016, ASM Journals

    Dr. Mariana Castanheira

  31. Klebsiella pneumoniae Isolate from a New York City Hospital Belonging to Sequence Type 258 and CarryingblaKPC-2andblaVIM-4

    Article • Antimicrobial Agents and Chemotherapy, January 2016, ASM Journals

    Dr. Mariana Castanheira

  32. β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Dr. Mariana Castanheira

  33. Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011–2014)

    Article • Diagnostic Microbiology and Infectious Disease, December 2015, Elsevier

    Dr. Mariana Castanheira

  34. Update on dalbavancin activity tested against Gram-positive clinical isolates responsible for documented skin and skin-structure infections in US and European hospitals (2011–13): Table 1.

    Article • Journal of Antimicrobial Chemotherapy, October 2015, Oxford University Press (OUP)

    Dr. Mariana Castanheira

  35. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013)

    Article • Diagnostic Microbiology and Infectious Disease, October 2015, Elsevier

    Dr. Mariana Castanheira

  36. Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis

    Article • Medical Mycology, September 2015, Oxford University Press (OUP)

    Dr. Mariana Castanheira

  37. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia

    Article • International Journal of Antimicrobial Agents, July 2015, Elsevier

    Dr. Mariana Castanheira

  38. Identification of Uncommon Clinically Important Yeasts and Moulds by the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) System in a Global Antifungal Surveillance Program

    Article • Medical Research Archives, June 2015, Knowledge Enterprise Journals

    Dr. Mariana Castanheira

  39. Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013

    Article • Diagnostic Microbiology and Infectious Disease, May 2015, Elsevier

    Dr. Mariana Castanheira

  40. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010–2012)

    Article • The Journal of Antibiotics, April 2015, Nature

    Dr. Mariana Castanheira

  41. Ceftazidime-Avibactam Activity Tested against Enterobacteriaceae Isolates from U.S. Hospitals (2011 to 2013) and Characterization of β-Lactamase-Producing Strains

    Article • Antimicrobial Agents and Chemotherapy, April 2015, ASM Journals

    Dr. Mariana Castanheira

  42. Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in U.S. Medical Centers in 2012 and 2013

    Article • Antimicrobial Agents and Chemotherapy, April 2015, ASM Journals

    Helio S Sader, Dr. Mariana Castanheira

  43. In vitroantifungal susceptibilities of isolates ofCandidaspp. andAspergillusspp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012

    Article • Mycoses, February 2015, Wiley

    Mike Pfaller, Dr. Mariana Castanheira

  44. 116

    Article • Critical Care Medicine, December 2014, Wolters Kluwer Health

    Dr. Mariana Castanheira

  45. Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections

    Article • International Journal of Antimicrobial Agents, October 2014, Elsevier

    Dr. Mariana Castanheira

  46. Activity of Ceftaroline-Avibactam Tested Against Contemporary Enterobacteriaceae Isolates Carrying β-Lactamases Prevalent in the United States

    Article • Microbial Drug Resistance, October 2014, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  47. Evaluation of Clonality and Carbapenem Resistance Mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus Complex and Enterobacteriaceae Isolates Collected in European and Mediterranean Countries and Detection of Two Novel β-Lactamases, GE...

    Article • Antimicrobial Agents and Chemotherapy, September 2014, ASM Journals

    Dr. Mariana Castanheira

  48. Mutation-Driven β-Lactam Resistance Mechanisms among Contemporary Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates from U.S. Hospitals

    Article • Antimicrobial Agents and Chemotherapy, September 2014, ASM Journals

    Dr. Mariana Castanheira

  49. Regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!

    Article • Diagnostic Microbiology and Infectious Disease, September 2014, Elsevier

    Dr. Mariana Castanheira

  50. Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values

    Article • Mycopathologia, June 2014, Springer Science + Business Media

    Dr. Mariana Castanheira

  51. Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

    Article • Journal of Clinical Microbiology, June 2014, ASM Journals

    Dr. Mariana Castanheira

  52. Candidemia surveillance in Iowa: emergence of echinocandin resistance

    Article • Diagnostic Microbiology and Infectious Disease, June 2014, Elsevier

    Dr. Mariana Castanheira

  53. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 Systemically active antifungal agents when tested against Candida spp.

    Article • Diagnostic Microbiology and Infectious Disease, June 2014, Elsevier

    Dr. Mariana Castanheira

  54. Reply: regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!

    Article • Diagnostic Microbiology and Infectious Disease, June 2014, Elsevier

    Dr. Mariana Castanheira

  55. Regional data analysis ofCandidanon-albicansstrains collected in United States medical sites over a 6-year period, 2006-2011

    Article • Mycoses, May 2014, Wiley

    Dr. Mariana Castanheira

  56. Resistance surveillance program report for selected European nations (2011)

    Article • Diagnostic Microbiology and Infectious Disease, April 2014, Elsevier

    Dr. Mariana Castanheira

  57. Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel

    Article • Journal of Chemotherapy, December 2013, Taylor & Francis

    Dr. Mariana Castanheira

  58. Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups

    Article • Antimicrobial Agents and Chemotherapy, November 2013, ASM Journals

    Dr. Mariana Castanheira

  59. Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011)

    Article • Diagnostic Microbiology and Infectious Disease, November 2013, Elsevier

    Dr. Mariana Castanheira

  60. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)

    Article • The Brazilian Journal of Infectious Diseases, November 2013, Elsevier

    Dr. Mariana Castanheira

  61. Retrospective Molecular Analysis of DIM-1 Metallo-β-Lactamase Discovered in Pseudomonas stutzeri from India in 2000

    Article • Antimicrobial Agents and Chemotherapy, October 2013, ASM Journals

    Dr. Mariana Castanheira

  62. Frequency offksMutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

    Article • Antimicrobial Agents and Chemotherapy, October 2013, ASM Journals

    Dr. Mariana Castanheira

  63. IMP-33, a New IMP Variant Detected in Pseudomonas aeruginosa from Sicily

    Article • Antimicrobial Agents and Chemotherapy, September 2013, ASM Journals

    Dr. Mariana Castanheira

  64. Rapid Expansion of KPC-2-ProducingKlebsiella pneumoniaeIsolates in Two Texas Hospitals due to Clonal Spread of ST258 and ST307 Lineages

    Article • Microbial Drug Resistance, August 2013, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  65. Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)

    Article • Antimicrobial Agents and Chemotherapy, April 2013, ASM Journals

    Dr. Mariana Castanheira

  66. Update on the prevalence and genetic characterization of NDM-1–producing Enterobacteriaceae in Indian hospitals during 2010

    Article • Diagnostic Microbiology and Infectious Disease, February 2013, Elsevier

    Dr. Mariana Castanheira

  67. Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance ...

    Article • Journal of Clinical Microbiology, October 2012, ASM Journals

    Dr. Mariana Castanheira

  68. Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial

    Article • Diagnostic Microbiology and Infectious Disease, September 2012, Elsevier

    Dr. Mariana Castanheira

  69. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010)

    Article • Diagnostic Microbiology and Infectious Disease, August 2012, Elsevier

    Dr. Mariana Castanheira

  70. Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen

    Article • Current Fungal Infection Reports, June 2012, Springer Science + Business Media

    Dr. Mariana Castanheira

  71. Advances in Antifungal Susceptibility Testing of Candida, 2010–2012

    Article • Current Fungal Infection Reports, June 2012, Springer Science + Business Media

    Dr. Mariana Castanheira

  72. Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

    Article • Mycopathologia, May 2012, Springer Science + Business Media

    Dr. Mariana Castanheira

  73. Comparison of Escherichia coli ST131 Pulsotypes, by Epidemiologic Traits, 1967–2009

    Article • Emerging Infectious Diseases, April 2012, Centers for Disease Control and Prevention (CDC)

    Dr. Mariana Castanheira

  74. Evaluation of quinolone resistance–determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones

    Article • Diagnostic Microbiology and Infectious Disease, March 2012, Elsevier

    Dr. Mariana Castanheira

  75. Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

    Article • Diagnostic Microbiology and Infectious Disease, November 2011, Elsevier

    Dr. Mariana Castanheira

  76. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method

    Article • Diagnostic Microbiology and Infectious Disease, October 2011, Elsevier

    Dr. Mariana Castanheira

  77. Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species ofCandida

    Article • Journal of Clinical Microbiology, September 2011, ASM Journals

    Dr. Mariana Castanheira

  78. Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins

    Article • Current Fungal Infection Reports, April 2011, Springer Science + Business Media

    Dr. Mariana Castanheira

  79. Molecular typing of antimicrobial-resistant Shiga-toxin-producing Escherichia coli strains (STEC) in Brazil

    Article • Research in Microbiology, February 2011, Elsevier

    Dr. Mariana Castanheira

  80. Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci

    Article • International Journal of Antimicrobial Agents, January 2011, Elsevier

    Mr Douglas J Biedenbach, Dr. Mariana Castanheira

  81. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Ant...

    Article • Diagnostic Microbiology and Infectious Disease, January 2011, Elsevier

    Dr. Mariana Castanheira

  82. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)

    Article • Journal of Infection, December 2010, Elsevier

    Dr. Mariana Castanheira

  83. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

    Article • Diagnostic Microbiology and Infectious Disease, November 2010, Elsevier

    Dr. Mariana Castanheira

  84. First Description of bla CTX-M-14 - and bla CTX-M-15 -Producing Escherichia coli Isolates in Brazil

    Article • Microbial Drug Resistance, September 2010, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  85. Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug‐Resistant E. coli Infections in the United States

    Article • Clinical Infectious Diseases, August 2010, Oxford University Press (OUP)

    Dr. Mariana Castanheira

  86. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates

    Article • International Journal of Antimicrobial Agents, June 2010, Elsevier

    Mr Douglas J Biedenbach, Dr. Mariana Castanheira

  87. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria

    Article • Diagnostic Microbiology and Infectious Disease, April 2010, Elsevier

    Dr. Mariana Castanheira

  88. Antimicrobial Susceptibility Patterns of KPC-Producing or CTX-M-Producing Enterobacteriaceae

    Article • Microbial Drug Resistance, March 2010, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  89. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada

    Article • International Journal of Antimicrobial Agents, March 2010, Elsevier

    Dr. Mariana Castanheira

  90. Performance of Fusidic Acid (CEM-102) Susceptibility Testing Reagents: Broth Microdilution, Disk Diffusion, and Etest Methods as Applied toStaphylococcus aureus

    Article • Journal of Clinical Microbiology, January 2010, ASM Journals

    Dr. Mariana Castanheira

  91. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.

    Article • Diagnostic Microbiology and Infectious Disease, April 2009, Elsevier

    Dr. Mariana Castanheira

  92. Dissemination of a bla VIM-2 -Carrying Integron Among Enterobacteriaceae Species in Mexico: Report from the SENTRY Antimicrobial Surveillance Program

    Article • Microbial Drug Resistance, March 2009, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  93. Dissemination of blaIMP-1-carrying integron In86 among Klebsiella pneumoniae isolates harboring a new trimethoprim resistance gene dfr23

    Article • Diagnostic Microbiology and Infectious Disease, January 2009, Elsevier

    Dr. Mariana Castanheira

  94. United States resistance surveillance results for linezolid (LEADER Program for 2007)

    Article • Diagnostic Microbiology and Infectious Disease, December 2008, Elsevier

    Dr. Mariana Castanheira

  95. Rapid Emergence of bla CTX-M Among Enterobacteriaceae in U.S. Medical Centers: Molecular Evaluation from the MYSTIC Program (2007)

    Article • Microbial Drug Resistance, September 2008, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  96. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006)

    Article • Diagnostic Microbiology and Infectious Disease, June 2008, Elsevier

    Dr. Mariana Castanheira

  97. In71, an Enterobacter cloacae bla VIM-1 -Carrying Integron Related to In70.2 from Italian Pseudomonas aeruginosa Isolates: A SENTRY Antimicrobial Surveillance Program Report

    Article • Microbial Drug Resistance, June 2007, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  98. Carriage of methicillin-resistant Staphylococcus aureus in children in Brazil

    Article • Diagnostic Microbiology and Infectious Disease, April 2007, Elsevier

    Dr. Mariana Castanheira

  99. Changing Antimicrobial Susceptibility Patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998–2004)

    Article • Microbial Drug Resistance, June 2006, Mary Ann Liebert Inc

    Dr. Mariana Castanheira

  100. Metalo-beta-lactamases

    Article • Jornal Brasileiro de Patologia e Medicina Laboratorial, April 2006, FapUNIFESP (SciELO)

    Dr. Mariana Castanheira

  101. Dissemination and diversity of metallo-β-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program

    Article • International Journal of Antimicrobial Agents, January 2005, Elsevier

    Dr. Mariana Castanheira

  102. Typing and Molecular Characterization of Streptococcus pneumoniae with Reduced Susceptibility to Cefotaxime Isolated in Latin America

    Article • Microbial Drug Resistance, December 2003, Mary Ann Liebert Inc

    Dr. Mariana Castanheira